Edelweiss is a prominent financial services conglomerate in India, providing a comprehensive platform for a diverse range of clients both domestically and internationally. The company supports customers at every stage of their financial journey, assisting them in wealth creation, growth, and protection. The Company is in the business…
The Wealth Company Liquid Fund NFO Quick Reasons to Invest: (source: wealthcompanyamc.in) The Wealth Company Liquid Fund NFO Investment Objective: The investment objective of the scheme is to provide opportunity to invest in a portfolio of money market and debt securities having maturity of up to 91 days…
The Wealth Company Flexi Cap Fund NFO Quick Reasons to Invest: (source: wealthcompanyamc.in) The Wealth Company Flexi Cap Fund NFO Investment Objective: To provide long-term growth in capital and income to investors, through active management of investments in a diversified portfolio of equity and equity-related securities across the…
THE WEALTH COMPANY ETHICAL FUND NFO Quick Reasons to Invest: Why Ethical? A refined way of investing The Ethical Fund is more than wealth creation — it is prosperity with purpose. Unlike ESG, which is compliance-driven, or impact investing, which is theme-based, ethical investing is deeply personal and…
Muthoot Microfin Limited, one of India’s leading microfinance institutions, has successfully mobilized ₹50 crore through the private placement of non-convertible debentures (NCDs). The issue reflects the company’s continued ability to attract institutional investors while diversifying its funding mix to support growth in the microfinance sector. Key Terms of…
Dilip Buildcon Ltd (DBL) has been declared the lowest (L-1) bidder for a major infrastructure project under the Kerala Industrial Corridor Development Corporation, valued at ₹1,115.37 crore. The project involves the design, construction, testing, commissioning, and operations and maintenance (O&M) of industrial corridor infrastructure at Pudussery Central and…
Shilpa Medicare Limited has received initial authorization from the European Medicines Agency (EMA) for its Rivaroxaban Orodispersible Films (ODF), a generic alternative to Bayer AG’s blockbuster anticoagulant, Xarelto®. The approval covers 10 mg, 15 mg, and 20 mg strengths, paving the way for final marketing authorization in Europe.…
Infosys Ltd, a global leader in digital services and consulting, has announced an expansion of its long-standing strategic partnership with Sunrise, Switzerland’s second-largest telecom provider. The move, revealed on September 23, underscores a shared ambition to accelerate IT transformation and prepare the telecom major for an AI-powered future.…
The Wealth Company Arbitage Fund NFO Quick Reasons to Invest: (source: wealthcompanyamc.in) The Wealth Company Arbitage Fund NFO Investment Objective: To generate income through arbitrage opportunities and debt and money market instruments. (source: wealthcompanyamc.in) The Wealth Company Arbitage Fund NFO: Mutual Fund The Wealth Company Mutual Fund Scheme…
Several listed companies are in the spotlight today owing to fresh agreements, acquisitions, production updates, and regulatory approvals. Here’s a roundup of the latest developments from corporate India: Technology & IT Services Infosys Extends Swiss CollaborationInfosys has extended its strategic collaboration with Switzerland’s Sunrise to accelerate IT transformation…
